Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sage Therapeutic Com
(NQ:
SAGE
)
13.11
-0.17 (-1.32%)
Official Closing Price
Updated: 4:15 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
914,531
Open
13.38
Bid (Size)
12.70 (1)
Ask (Size)
13.89 (1)
Prev. Close
13.28
Today's Range
12.84 - 13.46
52wk Range
10.92 - 59.99
Shares Outstanding
59,762,106
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SAGE Stock Earnings: Sage Therapeutics Misses EPS, Beats Revenue for Q1 2024
April 25, 2024
SAGE stock results show that Sage Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
April 25, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Performance
YTD
-41.70%
-41.70%
1 Month
-26.79%
-26.79%
3 Month
-48.89%
-48.89%
6 Month
-33.48%
-33.48%
1 Year
-71.23%
-71.23%
More News
Read More
Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
April 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 24, 2024
Via
Benzinga
In-Depth Examination Of 9 Analyst Recommendations For Sage Therapeutics
April 18, 2024
Via
Benzinga
Demystifying Sage Therapeutics: Insights From 5 Analyst Reviews
March 26, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Sage Therapeutics Through Analyst Insights
February 28, 2024
Via
Benzinga
Netflix, ON Semiconductor And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 19, 2024
Via
Benzinga
Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
April 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge
April 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data
April 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 17, 2024
Via
Benzinga
Earnings Scheduled For February 14, 2024
February 14, 2024
Via
Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 17, 2024
Via
Benzinga
Sage Stock Collapses To Record Low After Parkinson's Drug Misses Its Mark
April 17, 2024
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 17, 2024
Via
Benzinga
J B Hunt Transport Reports Downbeat Earnings, Joins ASML And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
April 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
April 17, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
April 11, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Present at Upcoming March Investor Conferences
February 28, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
These Analysts Boost Their Forecasts On Sage Therapeutics Following Q4 Results
February 15, 2024
Via
Benzinga
Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
February 14, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 14, 2024
January 31, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare Conference
January 08, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics Announces Changes to Board of Directors
January 08, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.